BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36644279)

  • 21. Pervasive nuclear envelope ruptures precede ECM signaling and disease onset without activating cGAS-STING in Lamin-cardiomyopathy mice.
    En A; Bogireddi H; Thomas B; Stutzman AV; Ikegami S; LaForest B; Almakki O; Pytel P; Moskowitz IP; Ikegami K
    Cell Rep; 2024 May; 43(6):114284. PubMed ID: 38814785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lamin A/C Cardiomyopathies: Current Understanding and Novel Treatment Strategies.
    Wang X; Zabell A; Koh W; Tang WH
    Curr Treat Options Cardiovasc Med; 2017 Mar; 19(3):21. PubMed ID: 28299614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multi-level transcriptomic analysis of
    Zuela-Sopilniak N; Morival J; Lammerding J
    bioRxiv; 2024 Jun; ():. PubMed ID: 38915720
    [No Abstract]   [Full Text] [Related]  

  • 24. Identification of novel mutations in LMNA associated with familial forms of dilated cardiomyopathy.
    Stallmeyer B; Koopmann M; Schulze-Bahr E
    Genet Test Mol Biomarkers; 2012 Jun; 16(6):543-9. PubMed ID: 22224630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of a human induced pluripotent stem cell line derived from a patient with dilated cardiomyopathy carrying LMNA nonsense mutation.
    Shimoda Y; Murakoshi N; Mori H; Xu D; Tajiri K; Hemmi Y; Sato I; Noguchi M; Nakamura Y; Hayashi Y; Ieda M
    Stem Cell Res; 2022 Jul; 62():102793. PubMed ID: 35500377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cGAS-STING signaling in cardiovascular and metabolic diseases: Future novel target option for pharmacotherapy.
    Oduro PK; Zheng X; Wei J; Yang Y; Wang Y; Zhang H; Liu E; Gao X; Du M; Wang Q
    Acta Pharm Sin B; 2022 Jan; 12(1):50-75. PubMed ID: 35127372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lamin A/C mutations in dilated cardiomyopathy.
    Tesson F; Saj M; Uvaize MM; Nicolas H; Płoski R; Bilińska Z
    Cardiol J; 2014; 21(4):331-42. PubMed ID: 24846508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel deletion mutation accompanied by a point mutation in Lamin A/C gene: Screened from a dilated cardiomyopathy family.
    Jia H; Sun Y; Yao W; Chen Z; Yang S; Wang C; Lu S
    Perfusion; 2023 May; 38(4):826-836. PubMed ID: 35514053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease.
    Fatkin D; MacRae C; Sasaki T; Wolff MR; Porcu M; Frenneaux M; Atherton J; Vidaillet HJ; Spudich S; De Girolami U; Seidman JG; Seidman C; Muntoni F; Müehle G; Johnson W; McDonough B
    N Engl J Med; 1999 Dec; 341(23):1715-24. PubMed ID: 10580070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Features of LMNA-Related Cardiomyopathy in 18 Patients and Characterization of Two Novel Variants.
    Ferradini V; Cosma J; Romeo F; De Masi C; Murdocca M; Spitalieri P; Mannucci S; Parlapiano G; Di Lorenzo F; Martino A; Fedele F; Calò L; Novelli G; Sangiuolo F; Mango R
    J Clin Med; 2021 Oct; 10(21):. PubMed ID: 34768595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo and in vitro examination of the functional significances of novel lamin gene mutations in heart failure patients.
    Sylvius N; Bilinska ZT; Veinot JP; Fidzianska A; Bolongo PM; Poon S; McKeown P; Davies RA; Chan KL; Tang AS; Dyack S; Grzybowski J; Ruzyllo W; McBride H; Tesson F
    J Med Genet; 2005 Aug; 42(8):639-47. PubMed ID: 16061563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Case reports of a c.475G>T, p.E159* lamin A/C mutation with a family history of conduction disorder, dilated cardiomyopathy and sudden cardiac death.
    Yokokawa T; Ichimura S; Hijioka N; Kaneshiro T; Yoshihisa A; Kunii H; Nakazato K; Ishida T; Suzuki O; Ohno S; Aiba T; Ohtani H; Takeishi Y
    BMC Cardiovasc Disord; 2019 Dec; 19(1):298. PubMed ID: 31847799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Yin Yang 1 Suppresses Dilated Cardiomyopathy and Cardiac Fibrosis Through Regulation of
    Tan CY; Wong JX; Chan PS; Tan H; Liao D; Chen W; Tan LW; Ackers-Johnson M; Wakimoto H; Seidman JG; Seidman CE; Lunde IG; Zhu F; Hu Q; Bian J; Wang JW; Foo RS; Jiang J
    Circ Res; 2019 Oct; 125(9):834-846. PubMed ID: 31495264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defects in nuclear structure and function promote dilated cardiomyopathy in lamin A/C-deficient mice.
    Nikolova V; Leimena C; McMahon AC; Tan JC; Chandar S; Jogia D; Kesteven SH; Michalicek J; Otway R; Verheyen F; Rainer S; Stewart CL; Martin D; Feneley MP; Fatkin D
    J Clin Invest; 2004 Feb; 113(3):357-69. PubMed ID: 14755333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An LMNA synonymous variant associated with severe dilated cardiomyopathy: Case report.
    Gao S; Mumme-Monheit A; Chen SN; Spector EB; Slavov D; Baralle FE; Bristow MR; Mestroni L; Taylor MRG;
    Am J Med Genet A; 2022 Feb; 188(2):600-605. PubMed ID: 34652067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of late sodium current attenuates ionic arrhythmia mechanism in ventricular myocytes expressing LaminA-N195K mutation.
    Markandeya YS; Tsubouchi T; Hacker TA; Wolff MR; Belardinelli L; Balijepalli RC
    Heart Rhythm; 2016 Nov; 13(11):2228-2236. PubMed ID: 27498076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dual specificity phosphatase 4 mediates cardiomyopathy caused by lamin A/C (LMNA) gene mutation.
    Choi JC; Wu W; Muchir A; Iwata S; Homma S; Worman HJ
    J Biol Chem; 2012 Nov; 287(48):40513-24. PubMed ID: 23048029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics.
    van Tintelen JP; Hofstra RM; Katerberg H; Rossenbacker T; Wiesfeld AC; du Marchie Sarvaas GJ; Wilde AA; van Langen IM; Nannenberg EA; van der Kooi AJ; Kraak M; van Gelder IC; van Veldhuisen DJ; Vos Y; van den Berg MP;
    Am Heart J; 2007 Dec; 154(6):1130-9. PubMed ID: 18035086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The LMNA p.R541C mutation causes dilated cardiomyopathy in human and mice.
    Yang L; Sun J; Chen Z; Liu L; Sun Y; Lin J; Hu X; Zhao M; Ma Y; Lu D; Li Y; Guo Y; Dong E
    Int J Cardiol; 2022 Sep; 363():149-158. PubMed ID: 35714719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nuclear damage in
    Wallace M; Zahr H; Perati S; Morsink CD; Johnson LE; Gacita AM; Lai S; Wallrath LL; Benjamin IJ; McNally EM; Kirby TJ; Lammerding J
    Mol Biol Cell; 2023 Aug; 34(12):mbcE21100527. PubMed ID: 37585285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.